Cheddar is partnering with StackCommerce to bring you the Cheddar Shop. This article doesn’t constitute editorial endorsement, and we earn a portion of all sales.
With the plethora of streaming content out there, we often wind up spending more time flipping through titles than we do enjoying the show or movie we (finally) end up choosing. It’s not always to our satisfaction, either. How many times have you scrolled endlessly, only to be disappointed with your selection? Or you might find yourself mindlessly picking up your phone and starting to scroll soon after the opening credits.
Upgrade your next movie night with the CuriosityStream HD Plan: Lifetime Subscription. The award-winning streaming service features thousands of documentaries covering myriad topics. No dull docs here: CuriosityStream fuses top-tier storytelling and dazzling visuals for a viewing experience so immersive, you won’t even think about your IG feed.
Launched by John Hendricks, the media visionary behind Discovery Communications, CuriosityStream features documentaries across topics like history, nature, science, lifestyle and content for kids, including exclusive original programming. Tune into documentaries from experts like David Attenborough, whose segments dive deep into nature all around the world, as well as Michio Kaku and Brian Greene, who specialize in space, time and the future. New content is added weekly, so you’ll never run short on shows.
Watch in HD on your TV, smartphone, desktop or tablet. Use the download feature to ensure you can watch your shows anywhere, even without an internet connection. The smart features are super user friendly, too. Bookmark shows for later, resume watching a program on different devices, plus rate your favorite programs for personalized recommendations. CuriosityStream is also available on popular viewing platforms including Amazon Fire TV, Apple TV 4, Roku, Xbox One and more devices
Millions of subscribers already tune in to the world’s best documentaries on CuriosityStream, which boasts a 4.7-star rating on the Apple Store, 4.3-star rating on the Google Play store, plus 4 stars on PCMag. This catalog of documentaries, available for unlimited streaming, simply can't be beat.
Get the CuriosityStream HD Plan: Lifetime Subscription for $149.99 (Reg. $250), a savings of 40%.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
